Microscopic Polyangiitis (MPA) • 2017 “In 2017 I was diagnosed with MPA that would change my life forever. While my life changed, I learned over time to adapt and adjust to my new reality learning how to live with and thrive with Vasculitis.”...
Amgen Successfully Completes Acquisition of ChemoCentryx
TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat…...
